rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2008-3-17
|
pubmed:abstractText |
Growth factor based angiogenesis, with or without cell therapy, is a promising therapeutic modality for patients with coronary artery disease. We compared the relative efficacies of surgically delivered vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2) in a swine model of hypercholesterolemia-induced endothelial dysfunction which captures many of the pathophysiologic abnormalities of human coronary disease.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-10704610,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-10982554,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-10993861,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-11073878,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-12504809,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-12543640,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-12778163,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-12970256,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-14992878,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-15300208,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-15544033,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-16159817,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-16427865,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-16725109,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-16820608,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-16980878,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-17140946,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-9008168,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-9647055,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18201892-9852909
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1010-7940
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
645-50; discussion 251-2
|
pubmed:dateRevised |
2010-12-28
|
pubmed:meshHeading |
pubmed-meshheading:18201892-Animals,
pubmed-meshheading:18201892-Coronary Artery Disease,
pubmed-meshheading:18201892-Fibroblast Growth Factor 2,
pubmed-meshheading:18201892-Hypercholesterolemia,
pubmed-meshheading:18201892-Models, Animal,
pubmed-meshheading:18201892-Myocardial Ischemia,
pubmed-meshheading:18201892-Neovascularization, Physiologic,
pubmed-meshheading:18201892-Swine,
pubmed-meshheading:18201892-Swine, Miniature,
pubmed-meshheading:18201892-Treatment Outcome,
pubmed-meshheading:18201892-Vascular Endothelial Growth Factor A
|
pubmed:year |
2008
|
pubmed:articleTitle |
Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction.
|
pubmed:affiliation |
Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, N.I.H., Extramural
|